Dafna Capital Trims IShares ETF: Biotech Portfolio Moves
A major move by a prominent asset manager reveals how large portfolios tweak biotech bets. Learn what the trim means ...
Looking for low-effort income? Check out ways to make money with minimal effort and maximize your earnings without a lot of work.
14,428 articlesA major move by a prominent asset manager reveals how large portfolios tweak biotech bets. Learn what the trim means ...
Monero's XMR remains in a tight range around the mid-$180s as liquidity thins. Analysts say the trapped setup could f...
CEOs are shifting from a single forecast to multi-scenario, wartime-style planning to weather shocks. CFOs play a piv...
With earnings on the horizon and a bold pivot to AI infrastructure, investors face a tough call. This guide breaks do...
Feeling unsure about Pinterest in your portfolio? This practical guide breaks down how to decide if you should sell P...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...
As gold prices stabilize after a broad correction, two gold mining stocks poised for a rebound are drawing fresh inte...
Shiba Inu ceded its top meme-coin ranking to MemeCore as interest shifts in the volatile meme-coin market. This repor...
Geopolitical tensions push fuel costs higher, prompting DoorDash to fund more than $50 million in gas-price relief fo...
A new wave of small modular reactors could reshape the US power mix. This article explains why NuScale Power is catch...
Teads released its Q1 2026 results, showing resilience in a volatile ad market. This investor-focused guide breaks do...
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...